Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma”.
Yvette L. Kasamon, Justin S. Collazo, Ruby Leong, Kun Wang, P Li +8 more
James Buturla, Christy Osgood, Xin Gao, Wei Chen, Tiffany K. Ricks +14 more
Kamar Godder, Jingyan Wang, Justin S. Collazo, Robyn Konicki, Moran Choe +15 more